Rich Edwards
Seminars
Wednesday 2nd December 2026
Roundtable Discussion: Is Actinium-225 Ready for Mainstream Clinical Adoption? Balancing Scientific Promise with Development Reality
11:45 am
- Evaluating where Actinium-225 offers meaningful clinical advantages over established beta-emitting radionuclides to maximise patient benefit
- Overcoming isotope supply, manufacturing and infrastructure constraints to enable sustainable clinical development and future commercialisation
- Optimising target selection, dosimetry and therapeutic index to improve efficacy while minimising off-target toxicity
Thursday 3rd December 2026
Accelerating GMP Tech Transfer: Translating Novel Radiopharmaceutical Platforms from Discovery to First-in- Human
11:30 am
- Preparing novel radiopharmaceutical technologies for successful GMP tech transfer and clinical manufacturing
- Lessons learned navigating analytical, CMC and operational challenges during technology transfer
- Coordinating discovery, manufacturing and clinical teams to enable seamless progression into Phase I
- Key considerations for de-risking technology transfer while maintaining programme momentum
